Company Profiles

driven by the PitchBook Platform

Hepregen

Description

Developer of bio-engineering technology for drug discovery and development applications in the pharmaceutical industry. The company develops and commercializes HepatoPac, a bio-engineered micro-liver platform for use in a range of applications, including metabolite identification, toxicity screening, clearance, drug-drug interactions, transporter involvement, in silico models, toxicogenomics and disease modeling applications in humans.

2007

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$500k

Latest Deal Amount

$10.2M

Total Amount Raised

Description

Developer of bio-engineering technology for drug discovery and development applications in the pharmaceutical industry. The company develops and commercializes HepatoPac, a bio-engineered micro-liver platform for use in a range of applications, including metabolite identification, toxicity screening, clearance, drug-drug interactions, transporter involvement, in silico models, toxicogenomics and disease modeling applications in humans.

Website:

www.hepregen.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

200 Boston Avenue Suite 1500 Medford, MA 02155United States +1 (781) 391-0205
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Hepregen's full profile, request a free trial.

Hepregen Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Hepregen Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Hepregen Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Battelle VenturesVenture CapitalMinority000 0000000 0000
Catalyst Health VenturesVenture CapitalMinority000 0000000 0000
Innovation Valley PartnersVenture CapitalMinority000 0000000 0000
National Institutes of HealthGovernment000 0000000 0000
Battelle Ventures Venture Capital
Catalyst Health Ventures Venture Capital
Innovation Valley Partners Venture Capital
National Institutes of Health Government

Hepregen Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Martin JoyceVice President, Finance and Administration & Chief Financial Officer
Sangeeta BhatiaCo-Founder & Head of SAB
John McGeehanVice President, Operations
Vincent Zurawski Ph.DChief Executive Officer, Board Member & President
Martin Joyce Vice President, Finance and Administration & Chief Financial Officer
Sangeeta Bhatia Co-Founder & Head of SAB
John McGeehan Vice President, Operations
Vincent Zurawski Ph.D Chief Executive Officer, Board Member & President

Hepregen Board Members (5)

NameRepresentingRoleSinceContact
Info
Elizabeth TallettSelfBoard Member000 0000
Joshua PhillipsCatalyst Health VenturesManaging Partner000 0000
Leslie WilliamsSelfBoard Director000 0000
Morton Collins Ph.DBattelle VenturesManaging Director000 0000
Robert WilkinsSelfBoard Member000 0000
Elizabeth Tallett Board Member Self
Joshua Phillips Managing Partner Catalyst Health Ventures
Leslie Williams Board Director Self
Morton Collins Ph.D Managing Director Battelle Ventures
Robert Wilkins Board Member Self
Request full access to PitchBook